Recevez les dernières nouvelles sur l'action iShares Biotechnology ETF avec des mises à jour sur les tendances du marché, les données financières et les analyses de Benzinga. Restez informé des performances de IBB

Dernières nouvelles pour

iShares Biotechnology ETF

Healthcare

Other

Financial Services

To pursue its objective, the Fund seeks to track the investment results of the NYSE Biotechnology Index (the Underlying Index), which measures the performance of U.S.-listed securities of companies that are classified according to the ICE Uniform Sector Classification schema within the Biotechnology Sub-Industry Group (as determined by ICE Data Indices, LLC or its affiliates (collectively Index Provider or IDI)) and that also meet other eligibility criteria determined by the Index Provider, including minimum market capitalization and liquidity requirements. Companies classified within the Biotechnology Sub-Industry Group include those companies that are engaged in the research and development of therapeutic treatments but that are not focused on the commercialization and mass production of pharmaceutical drugs..

Gilead Sciences Inc

Regeneron

Nvaesrtex Pharmaceuticals Inc

Amgen Inc.

I Q V I A Holdings Inc.

Moderna therapeutics

Mettler-Toledo International Inc.

Biogen Inc. Com

Alnylam Pharmace

Argenx Se Ads

Waters Corp.

Biontech Se

Natera Inc

Insmed Inc

Invesco Nasdaq Biotechnology ETF

Invesco Bloomberg Commodity UCITS ETF

Press Releases

Altimmune Added to Nasdaq Biotechnology Index

iShares Nasdaq Biotechnology Index Fund

Comments

iShares Biotechnology ETF Actualités boursières

Actualités

Dernières nouvelles pour

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL